Research ExplorerPublicationsAdvances in Rapid Identification and Susceptibility Testing ...

Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs

Standard

Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs. / Maurer, Florian P; Christner, Martin; Hentschke, Moritz; Rohde, Holger.

In: INFECT DIS REP, Vol. 9, No. 1, 30.03.2017, p. 6839.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Maurer, FP, Christner, M, Hentschke, M & Rohde, H 2017, 'Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs', INFECT DIS REP, vol. 9, no. 1, pp. 6839. https://doi.org/10.4081/idr.2017.6839

APA

Maurer, F. P., Christner, M., Hentschke, M., & Rohde, H. (2017). Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs. INFECT DIS REP, 9(1), 6839. https://doi.org/10.4081/idr.2017.6839

Vancouver

Maurer FP, Christner M, Hentschke M, Rohde H. Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs. INFECT DIS REP. 2017 Mar 30;9(1):6839. https://doi.org/10.4081/idr.2017.6839

Bibtex

@article{7acb3d323764427b8776ecdfd2cad67f,
title = "Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs",
abstract = "Early availability of information on bacterial pathogens and their antimicrobial susceptibility is of key importance for the management of infectious diseases patients. Currently, using traditional approaches, it usually takes at least 48 hours for identification and susceptibility testing of bacterial pathogens. Therefore, the slowness of diagnostic procedures drives prolongation of empiric, potentially inappropriate, antibacterial therapies. Over the last couple of years, the improvement of available techniques (e.g. for susceptibility testing, DNA amplification assays), and introduction of novel technologies (e.g. MALDI-TOF) has fundamentally changed approaches towards pathogen identification and characterization. Importantly, these techniques offer increased diagnostic resolution while at the same time shorten the time-to-result, and are thus of obvious importance for antimicrobial stewardship. In this review, we will discuss recent advances in medical microbiology with special emphasis on the impact of novel techniques on antimicrobial stewardship programs.",
keywords = "Journal Article, Review",
author = "Maurer, {Florian P} and Martin Christner and Moritz Hentschke and Holger Rohde",
year = "2017",
month = mar,
day = "30",
doi = "10.4081/idr.2017.6839",
language = "English",
volume = "9",
pages = "6839",
journal = "INFECT DIS REP",
issn = "2036-7430",
publisher = "PAGEPress",
number = "1",

}

RIS

TY - JOUR

T1 - Advances in Rapid Identification and Susceptibility Testing of Bacteria in the Clinical Microbiology Laboratory:Implications for Patient Care and Antimicrobial Stewardship Programs

AU - Maurer, Florian P

AU - Christner, Martin

AU - Hentschke, Moritz

AU - Rohde, Holger

PY - 2017/3/30

Y1 - 2017/3/30

N2 - Early availability of information on bacterial pathogens and their antimicrobial susceptibility is of key importance for the management of infectious diseases patients. Currently, using traditional approaches, it usually takes at least 48 hours for identification and susceptibility testing of bacterial pathogens. Therefore, the slowness of diagnostic procedures drives prolongation of empiric, potentially inappropriate, antibacterial therapies. Over the last couple of years, the improvement of available techniques (e.g. for susceptibility testing, DNA amplification assays), and introduction of novel technologies (e.g. MALDI-TOF) has fundamentally changed approaches towards pathogen identification and characterization. Importantly, these techniques offer increased diagnostic resolution while at the same time shorten the time-to-result, and are thus of obvious importance for antimicrobial stewardship. In this review, we will discuss recent advances in medical microbiology with special emphasis on the impact of novel techniques on antimicrobial stewardship programs.

AB - Early availability of information on bacterial pathogens and their antimicrobial susceptibility is of key importance for the management of infectious diseases patients. Currently, using traditional approaches, it usually takes at least 48 hours for identification and susceptibility testing of bacterial pathogens. Therefore, the slowness of diagnostic procedures drives prolongation of empiric, potentially inappropriate, antibacterial therapies. Over the last couple of years, the improvement of available techniques (e.g. for susceptibility testing, DNA amplification assays), and introduction of novel technologies (e.g. MALDI-TOF) has fundamentally changed approaches towards pathogen identification and characterization. Importantly, these techniques offer increased diagnostic resolution while at the same time shorten the time-to-result, and are thus of obvious importance for antimicrobial stewardship. In this review, we will discuss recent advances in medical microbiology with special emphasis on the impact of novel techniques on antimicrobial stewardship programs.

KW - Journal Article

KW - Review

U2 - 10.4081/idr.2017.6839

DO - 10.4081/idr.2017.6839

M3 - SCORING: Journal article

C2 - 28458798

VL - 9

SP - 6839

JO - INFECT DIS REP

JF - INFECT DIS REP

SN - 2036-7430

IS - 1

ER -